Council for Tobacco Research
Agenda for Ctr-Ma Meeting September 10,1981 [Items to Be Covered During Meeting.]
Abstract
MAR
Fields
- Type
- AGENDA
- OUTLINE
- Depository Date
- 31 Jan 1996
- Named Person
- Mai
- Walton
- Master ID
- 300200550-0634
- HT0121089-1094 Lung Cancer [Status of Publications.]
- HT0121095-1099 Dosimetry [Status of Publications.]
- HT0121100-1103 Pharmacokinetics,Metabolism [Status of Publications.]
- HT0121104-1104 Lack of Effect of Exposure to Whole Cigarette Smoke on Oocyte Depletion in Bc3f1/Cum Mice [Status of Publications.]
- HT0121105-1108 Smoke-Induced Short-Term Endpoints [Status of Publications.]
- HT0121109-1110 Induction of Ornithine Decarboxylase (Odc) by 12-0-Tetradecanoyl-Phorbol-13-Acetate (Tpa) in Pulmonary Tissue A Model System for Tumor Promotion in Mouse Lungs [Status of Drafts for Publications]
- HT0121111-1116 Other [Status of Publications.]
- HT0121117-1117 III. Experimental Update [Cover Sheet]
- HT0121118-1147 Ctr 101a Chronic Exposure of Bc3f1/Cum Mice to 2r1 Cigarette Smoke [Lung Diagnosis.]
- HT0121148-1172 Ctr 101b Exposure of Bc3f1/Cum Mice to 2r1 and 3a1 Cigarette Smoke for One Year [Results of Experiment]
Related Documents:
Document Images
H i N012"I ua
AGENDA FOR CTR - MA MEETING
September 10, 4aff
i ys,
I. Termination
A. Personnel
B. Facilities
C. Equipment
1. Transfer to Kentucky .
2. Purchases by MA
0. Ciga rettes
II. Manuscripts
A. List of publications to date
B. Status of recent publications
1. lung cancer
a. lung cancer model system
b. 2A1 smoke and MCA carcinogenesis
c. other
2. Dosimetry
a. Wal ton
b. SEM
3. Pharmacokinetics/metabolism
a. catechol in smoke
b. DTC, nicotine, and BaP in smoke
c. urinary metabolites of catechol
4. Atresia
5. Smoke induced short-term endooints
a. sister chromatid exchange
b. imnunosuppression
c. DNA labeling index
d. DNA repair
6. Genetic regulation of AHH/ODC
7. Aerosol
a. TPA/ODC
D. TPA dosimetry
8. Other
a. review article "In Vitro Assays for Cigarette Smoke
b.
c. Condensates"
human AHH (rcmarks and manuscripts)
XTV studies (remarks and manuscripts)
d. effects of Sendai virus (remarks and manuscripts)
III. Experimental Update
A. C-1olA .
1. Status
2. Animals
3. Pathology
4. Statistical evaluation
B. C-101B
1. Dosimetry
2. Short-term endpoints
